Back to search
FDAFDA · Food and drugs·Recall number D-0085-2022

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05

Published November 10, 2021 · Recall initiated: October 5, 2021

Summary

FDA records drug Class II recall D-0085-2022, published November 10, 2021 and initiated October 5, 2021. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 696 bottles; Lot: L100208, exp 01/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

What to do

Voluntary: Firm initiated · Letter

Get an email if EZETIMIBE AND SIMVASTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EZETIMIBE AND SIMVASTATIN
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the US
UPC
0343598745909
Lot
L100208, exp 01/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05 recalled?

Yes. FDA published recall D-0085-2022 on November 10, 2021. Reported hazard: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EZETIMIBE AND SIMVASTATIN. UPC: 0343598745909.